Tackling a deadly virus in farmed fish
The novel vaccine is designed using two core biological components – one to train the fish’s immune system and another to deliver the training module safely:
1. An “imposter” virus
The researchers used the NNV outer shell, known as the capsid protein, to create Virus-Like Particles (VLPs). The VLPs are hollow, non-infectious replicas of the virus. As the VLPs look identical to NNV externally, they trigger an immune response within the fish. However, they do not contain genetic material and are hence incapable of causing disease.
2. A delivery vehicle
The researchers needed a carrier to get the VLPs to the right place in the fish’s body and chose Lactococcus lactis, a safe and well-understood bacterium. The VLPs were encapsulated inside the bacterial cells, which act as protective capsules. The capsule shields the VLPs as they travel through the fish’s digestive system, ensuring they arrive in the gut where an immune response can be triggered.
A challenge for the scientists was finding the perfect formula for the bacterium-encased VLPs to be delivered successfully to and released in the gut. After trials with live and heat-treated Lactococcus lactis, the researchers found that inactivating the bacteria with sodium hypochlorite protected the VLP’s structure and solubility within the bacteria, ensuring that it could be delivered effectively to the immune system.
The novel oral vaccine produced outstanding results as a method to protect fish against NNV. It induced two-times the levels of antibodies and neutralising antibodies – antibodies which bind to pathogens and prevent them from entering host cells – compared to feeding the fish purified VLPs directly which is also a much more expensive method.
The vaccine was also proven to reduce brain viral load by about 300 times after fish were exposed to NNV for seven days. This means the vaccine dramatically reduced the amount of virus replicating in the fish, effectively protecting them from the lethal effects of the disease.